Breast Cancer Clinical Trial
Analyzing the Composition of Tears to Identify Cancer
Summary
This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.
Full Description
Specifically, this study will compare the protein profile in tear fluid from patients with breast, ovarian or colon cancer versus "normal male and female patients" for differences that show promise as a diagnostic indicator. If such differences can be found, then their diagnostic potential will be assessed and developed further in a subsequent study. The long-term goal of this project will be to develop a screening tool for the detection of breast and/or other cancers.
Eligibility Criteria
Inclusion Criteria:
Female or male, 18-100 years old
Patients who present for a routine check-up
Patients who present for the evaluation of an abnormal exam or test (mammogram, ultrasound, MRI, PET, etc.)
May or may not have a mass present
Patients who present for the evaluation of a palpable lump or mass
Patients may be pre or post biopsy for a mass, as long as there is a portion of the mass remaining
Exclusion Criteria:
Patient < 18 y/o or > 100 y/o
Concurrent eye infection or trauma
Active conjunctivitis
Abnormal production of tears (too much or too little)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Little Rock Arkansas, 72205, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.